{"id":"paper-or-2026-089127","type":"book","url":"https://diginpl.com/books/paper-or-2026-089127","language":"en","name":"A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity","name_en":"A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity","name_ne":null,"description":"Oncology Research · Yang Liu, Lixue Chen, Peng Wang et al. · 2026","headline":"Oncology Research · Yang Liu, Lixue Chen, Peng Wang et al. · 2026","also_known_as":[],"summary":"","summary_more":[],"facts":[{"key":"authors","label":"Author","values":[{"text":"Yang Liu"},{"text":"Lixue Chen"},{"text":"Peng Wang"},{"text":"Xiaoli Ma"},{"text":"Shuaikang Pan"},{"text":"Dafu Yang"},{"text":"Tianyu Zhou"},{"text":"Fang Yu"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/or.2026.089127"}},{"key":"published","label":"Published","values":[{"text":"2026","date":"2026"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/or.2026.089127"}},{"key":"publisher","label":"Publisher","values":[{"text":"Tech Science Press"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/or.2026.089127"}},{"key":"journal","label":"Journal","values":[{"text":"Oncology Research"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/or.2026.089127"}},{"key":"doi","label":"DOI","values":[{"text":"10.32604/or.2026.089127","url":"https://doi.org/10.32604/or.2026.089127"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/or.2026.089127"}}],"office":null,"sections":[],"cited":[],"cited_from":null,"videos":[],"last_reviewed":null,"organizations":[],"same_as":["https://doi.org/10.32604/or.2026.089127"],"faq":[{"q":"Who wrote A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity?","a":"A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity was written by Yang Liu, Lixue Chen, Peng Wang, Xiaoli Ma."},{"q":"When was A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity first published?","a":"A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity was first published in 2026."}],"related":[],"places_in":[],"nearby":[],"image":null,"sources":[{"label":"Publisher record (DOI, via Crossref)","url":"https://doi.org/10.32604/or.2026.089127","license":null}],"license":null,"attribution":"Open-access publication. Read it free at the publisher: https://doi.org/10.32604/or.2026.089127.","cite":"\"A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity\". DigiNepal. Last updated 23 October 2026. https://diginpl.com/books/paper-or-2026-089127. Retrieved 14 November 2026.","date_modified":"2026-10-23T06:20:15Z","facts_checked":"2026-10-23","alternates":{"html":"https://diginpl.com/books/paper-or-2026-089127","en":"https://diginpl.com/books/paper-or-2026-089127","ne":null}}